Total Funding
24
43
Total FundingNon-equity Assistance raised
Growth Score
-5 pts
Heat Score
-22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
172727
ImmunArtes is a biotech company innovating vaccines and therapeutics.
- Olaf Schneewind: Chief Medical Officer
- Hwan Keun Kim: Chief Operating Officer
About the Company
ImmunArtes immune evasion mechanisms with increased rates of antibiotic resistance. They develop vaccines and therapeutics that will effectively neutralize MRSA's immune evasion. They provide patients with vaccination against staph infection. They intend to address the bacteria's immune evasion mechanism and demonstrate protection against
infection.
Women Founded
